Koers HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Aandelen
HDST
IL0010954050
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 7,43 mln. 1,95 mln. 1,83 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -31 mln. -8,14 mln. -7,62 mln. | Nettowinst (verlies) 2023 | -29 mln. -7,62 mln. -7,12 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 12,93 mln. 3,4 mln. 3,18 mln. | Nettoliquiditeiten 2023 | 6,46 mln. 1,7 mln. 1,59 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,46
x | K/w-verhouding 2023 |
-0,25
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20-09-15 |
Tamar Raz
CHM | Chairman | 60 | 18-05-14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31-08-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29-07-18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05-07-16 |
Orit Stav
BRD | Director/Board Member | 53 | 01-11-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |